119 filings
Page 4 of 6
8-K
hvect8
21 Apr 20
Pharma Announce Positive Results From Global KALM-2
7:41am
8-K
d0m6 4u8m
25 Mar 20
Cara Therapeutics Reports Clinical Updates
7:43am
8-K
0ddqxv4cif1lnxor
27 Feb 20
Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
4:10pm
8-K
2kl1yrw1iqx7hpcadif
14 Jan 20
Targeting Pruritus with Novel Peripherally - Restricted Kappa Agonist Therapeutics JP Morgan Healthcare Conference January 2020
8:00am
8-K
iahaw3pbgjfwt370
23 Dec 19
Departure of Directors or Certain Officers
8:00am
8-K
63m68qmg60cc29oak1
16 Dec 19
Regulation FD Disclosure
6:05am
8-K
0zc9wt0ccdochqxy35z7
3 Dec 19
Regulation FD Disclosure
9:15am
8-K
x9k 5de9yvijua5h
20 Nov 19
Other Events
4:10pm
8-K
bhqrgp1bmdbc9ew
5 Nov 19
Cara Therapeutics Reports Third Quarter 2019 Financial Results
4:05pm
8-K
ow5w3j4lqa0
21 Aug 19
Entry into a Material Definitive Agreement
8:02am
8-K
etpb5uvacze03dzq8bg
7 Aug 19
Cara Therapeutics Reports Second Quarter 2019 Financial Results
4:12pm
8-K
5nrdliula b7c
29 Jul 19
Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock
4:11pm
8-K
x8meg zhg4p83axwqy
24 Jul 19
Cara Therapeutics Announces Proposed Offering of Common Stock
4:15pm
8-K
u69kw5 cocg
12 Jul 19
Entry into a Material Definitive Agreement
4:10pm
8-K
yoooa
5 Jun 19
Submission of Matters to a Vote of Security Holders
5:19pm
8-K
zcipg3wrd r5sksl5
29 May 19
Cara Therapeutics Announces Positive Results From
7:17am
8-K
jdz92a8j971hwflnq
7 May 19
Cara Therapeutics Reports First Quarter 2019 Financial Results
4:10pm
8-K
v6j278sio52h
12 Mar 19
Cara Therapeutics Reports Fourth Quarter and Full Year 2018
4:10pm
8-K
0d28rsuvl5
6 Nov 18
Cara Therapeutics Reports Third Quarter 2018 Financial Results
4:11pm
8-K
yptnsgx57pum9ldf
23 Oct 18
Departure of Directors or Certain Officers
7:29am